Clee Medical and the SFITS collaborate to enable safer and more effective neurosurgery

The SWISS Foundation for Innovation and Training in Surgery (SFITS) is pleased to announce a strategic collaboration with Clee Medical SA, a pioneering startup developing next-generation neurotechnology for real-time intraoperative brain imaging and AI-guided navigation.

Clee Medical at the SFITS

This partnership aims to accelerate the validation and clinical adoption of Clee Medical’s technology, which enables surgeons to visualize brain anatomy and vasculature with unprecedented precision. By combining real-time, ultra-high-resolution imaging with AI-based anatomical detection, Clee Medical seeks to improve surgical accuracy, enhance patient safety, and expand access to advanced neurotherapies.

It will also enable early integration of its neuroimaging technology into surgical training and evaluation, fostering real-world feedback and engagement with key clinical stakeholders.

Finally, this collaboration will bring together Clee Medical’s groundbreaking neurotechnology with the SFITS Innovation Program in order to drive forward the next era of patient-centered innovation.

Matthew Lapinski, CEO of Clee Medical SA, said: 

“We are thrilled to partner with the SFITS, a recognized leader in surgical training and innovation. This collaboration will allow us to showcase and refine our technology in a highly relevant clinical environment, accelerating our mission to enable safer, more precise, and more effective neurosurgery.”

Dr. Jelena Godjevac, CEO of the SFITS, added:

“We are excited to welcome Clee Medical to our ecosystem. Their innovative approach to real-time brain visualization and surgical navigation aligns closely with our mission to advance surgical excellence.”